Skip to main content
Log in

Opioid consumption in Spain – the significance of a regulatory measure

  • PHARMACOEPIDEMIOLOGY AND PRESCRIPTION
  • Published:
European Journal of Clinical Pharmacology Aims and scope Submit manuscript

Abstract

Objective: To investigate the impact of new regulatory measures on opioid consumption in Spain during the period 1985–1998.

Methods: A search in the ECOM (Especialidades Consumo de Medicamentos) database of the Ministry of Health was made for the 1985–1998 period. This database contains information about drug preparations prescribed in primary care in the National Health System in Spain.

Results: Since 1985–1998, the overall opioid consumption has increased tenfold, from 94.7 DDD (defined daily dose) per million inhabitants per day to more than 1000 DDD. For the five drugs that require a special prescription form (morphine, methadone, pethidine, tilidine and fentanyl), the consumption has increased 13.5-fold.

Conclusion: A huge increase in opioid consumption has occurred. In this increase, changes in supply and, to a lesser extent, regulatory measures have played an important role.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

Author information

Authors and Affiliations

Authors

Additional information

Received: 23 April 1999 / Accepted in revised form: 8 August 1999

Rights and permissions

Reprints and permissions

About this article

Cite this article

García del Pozo, J., Carvajal García-Pando, A., Rueda de Castro, A. et al. Opioid consumption in Spain – the significance of a regulatory measure. E J Clin Pharmacol 55, 681–683 (1999). https://doi.org/10.1007/s002280050693

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1007/s002280050693

Navigation